Kal H B, Meijnders P J, Van Berkel A H, Van Bekkum D W
TNO Institute of Applied Radiobiology and Immunology, Rijswijk, The Netherlands.
In Vivo. 1991 Jul-Aug;5(4):301-6.
Seven rat bronchial cancers of various grades of differentiation were used to study responses to single doses of cytostatic drugs (mitomycin C, cisplatin, methotrexate, TCNU, CCNU, ifosfamide) when growing subcutaneously or in the lung. The endpoint was growth delay as calculated from tumour volume measurements using vernier callipers or radiography. Substantial differences were observed between the tumour lines in their response to the chemotherapeutic agents. The response of tumours implanted in the lung was less than that of flank implants of the same tumour line. TCNU and ifosfamide were the most consistently effective drugs, yielding growth delays of at least two tumour volume doubling times in the majority of the lines studied.
选用7例不同分化程度的大鼠支气管癌,研究其皮下或肺内生长时对单剂量细胞抑制药物(丝裂霉素C、顺铂、甲氨蝶呤、氯乙环己基亚硝脲、环己亚硝脲、异环磷酰胺)的反应。终点指标是根据用游标卡尺测量肿瘤体积或通过放射照相术计算得出的生长延迟。观察到不同肿瘤系对化疗药物的反应存在显著差异。植入肺内的肿瘤的反应小于同一肿瘤系侧腹植入的肿瘤。氯乙环己基亚硝脲和异环磷酰胺是最具持续疗效的药物,在所研究的大多数肿瘤系中产生的生长延迟至少为两个肿瘤体积倍增时间。